Imagine if doctors could spot Parkinson’s disease at its inception and treat the protein that triggers it before the disease can sicken the patient.
A team of researchers led by Basir Ahmad, a postdoctoral researcher at Michigan State University, has demonstrated that slow-wriggling alpha-synuclein proteins are the cause of aggregation, or clumping together,…    



Positive attitude helps in Parkinson’s battle

Parkinson’s Disease, a neurodegenerative disease, is often characterized by a variety of changes that can affect everyday life.

With symptoms ranging from tremors, difficulty with balance, and slowing of activities, Parkinson’s can threaten to alter the quality of life of almost 100,000 Canadians living with the disease. However, for one Kingston family, a Parkinson’s…    



Scripps Research Institute Team Identifies a Potential Cause of Parkinson’s Disease that May Lead to New Treatment Options

Deciphering what causes the brain cell degeneration of Parkinson’s disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson’s disease. The discovery could lead to new targets for…    



Novel Antibodies for Combating Alzheimer’s and Parkinson’s Disease

Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer’s disease and Parkinson’s disease, as well as Type 2 diabetes, according to a new study.

The onset of these devastating diseases is associated with the inappropriate clumping of proteins into particles that…    



People with Parkinson’s strengthen their balance

Leading classes to help people with Parkinson’s disease to do better with their flexibility and balance is something Anthony Krumbholz does in part to honor his father.

Krumbholz, a 34-year-old Muscatine firefighter, leads Delay the Disease classes at the Muscatine Community Y twice each week. His father, John, who lives with Parkinson’s disease, is…    



Medtronic’s Brain Device Improves Early-Stage Parkinson’s

Patients with early Parkinson’s disease who respond to drug therapy gain improvement in their symptoms and quality of life when they receive deep-brain stimulation from an implanted medical device, a study showed.

Brain stimulation is now reserved for advanced Parkinson’s patients with severe complications and inconsistent response to drug treatment. The findings suggest patients…    



Tau Transmission Model Opens Doors for New Alzheimer’s, Parkinson’s Therapies

Injecting synthetic tau fibrils into animal models induces Alzheimer’s-like tau tangles and imitates the spread of tau pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania being presented at the American Academy of Neurology’s 65th Annual Meeting in San Diego March 16-23, 2013.

This Alzheimer’s research, along…